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Problem Definition
• Cesarean deliveries (CD) account for 1/3 of all deliveries 
• Surgical site infections (SSI) are significantly more common after CD if a 
woman has been in labor or had ruptured membranes prior to delivery
• Treatment may require intravenous antibiotic administration, prolonged 
hospital stay, and carries a risk of sepsis or abscess formation
Measurement and Results, continued
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Intervention
• Three study time periods: 
• 1). 12 months prior to implementation of either intervention
• 2). 14 months of vaginal cleaning as infection prophylaxis
• 3). 16 months of vaginal cleansing and azithromycin as infection prophylaxis 
Measurement and Results
Next Steps
• The introduction of vaginal cleansing decreased the SSI rate by 33%, from 22.8% 
to 15.2% 
• The addition of azithromycin did not further lower that rate
• Next steps: examine timing of azithromycin administration in relation to skin 
incision as well as the effect of postoperative oral antibiotics in obese patients
Aims for Improvement 
We aimed to decrease our SSI rate by 30% by sequential implementation of 
vaginal cleaning1,2 and azithromycin3 for women who underwent a CD after 
having labored or experienced rupture of membranes. 
References
1. Haas DM, Morgan S, Contreras K. Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative 
infections. Cochrane Database Syst Rev. 2014 Dec 21;(12):CD007892. 
2. Tita A, Szychowski JM, Boggess K et al.  Adjunctive azithromycin prophylaxis for cesarean delivery.  New Eng J Medic.  2016. 375;1231-41.  
3. Tran TS, Jamulitrat S, Chongsuvivatwong V, Geater A.  Risk Factors for Postcesarean Surgical Site Infection. Obstet Gynecol. March 2000. 
95(3):367-37
Numbers expressed in n/total N(%)
DM, diabetes mellitus; GA, gestational age; HIV, human immunodeficiency virus 
Figure 1: A. Control chart primary outcome, any surgical site infections as defined by CDC. 
B. Compliance rate of vaginal cleansing. C. Compliance rate of azithromycin
Table 2: Secondary outcomes
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Table 1: Patient Demographics
2016 2017 2018
Vaginal Cleansing Vaginal Cleansing and Azithromycin
2019
Numbers expressed in n/total N(%)
ED, emergency department
Percentage of women receiving vaginal cleansing prior to CD
Percentage of women receiving azithromycin prior to CD
rimary outc me: Percentage of women by month with SSI
